Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss current criteria for resectability of liver metastases in patients with colorectal cancer and how they differ from past criteria
- Summarize clinical trial data supporting the use of systemic therapy to convert initially unresectable liver metastases to resectability
- Identify risks of neoadjuvant systemic therapy that may influence the feasibility and outcome of curative resection of liver metastases
- Discuss current options for therapy in patients who experience disease recurrence
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.